ENDOTARGET

Endotarget is developing novel small molecule therapeutics that harness the body's own natural protein disposal system (the ubiquitin proteasome system) to selectively and efficiently degrade and remove disease-causing proteins. We focus on high impact targets, identifying clinically validated biological pathways with key nodes or proteins that drive the pathogenesis of multiple serious diseases with limited or no known treatment options.